Future research should focus on understanding how Gal-3 modulates immune responses during viral infection and whether targeting Gal-3 can enhance antiviral immunity without exacerbating inflammation or causing immune-mediated damage. The gene discussed is LGALS3; the disease is viral infectious disease.